-
Product Insights
Head And Neck Cancer Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Head And Neck Cancer Global Clinical Trials Review, H2, 2017" provides an overview of Head And Neck Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Head And Neck Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Head And Neck Carcinoma Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Head And Neck Carcinoma Global Clinical Trials Review, H2, 2017" provides an overview of Head And Neck Carcinoma clinical trials scenario. This report provides top line data relating to the clinical trials on Head And Neck Carcinoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Duodenal Cancer Disease - Global Clinical Trials Review, H1 2019
GlobalData's clinical trial report, “Duodenal Cancer Global Clinical Trials Review, H1, 2019" provides an overview of Duodenal Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Duodenal Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Endometrial Cancer Disease - Global Clinical Trials Review, H1 2019
GlobalData's clinical trial report, “Endometrial Cancer Global Clinical Trials Review, H1, 2019" provides an overview of Endometrial Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Endometrial Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Sector Analysis
B-Cell Non-Hodgkin’s Lymphoma - Epidemiology Forecast to 2027
Non-Hodgkin’s lymphoma (NHL) refers to a group of cancers that develop in the lymphatic system. In NHL, the patient’s immune system is affected by the uncontrollable growth of malignant white blood cells, resulting in the body’s inability to fight infections and other diseases. NHL accounts for 90% of all malignant lymphomas. NHL is one of the most prevalent hematologic cancers in adults and is more commonly diagnosed in developed countries. B-cell lymphomas are the most common form of NHL diagnosed...
-
Sector Analysis
Multiple Myeloma - Global Drug Forecast and Market Analysis to 2027
Multiple myeloma (MM) is a cancer of abnormal plasma cells, a type of white blood cell that is normally responsible for producing antibodies in the bone marrow. It is the second most common hematological malignancy in the US, and constitutes less than 1% of all cancer types. Multiple myeloma is not considered curable, but is treatable, with many therapies being generic steroids, and chemotherapies. Significant improvements in treatment outcome were achieved with the introduction of the immunomodulatory (IMiD) agents Thalomid...
-
Product Insights
Chronic Myelomonocytic Leukemia (CMML) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
The Chronic Myelomonocytic Leukemia clinical trial market research report provides top-line data relating to the clinical trials on Chronic Myelomonocytic Leukemia (CMML). The report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. It also offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type.
-
Product Insights
Colon Cancer Disease - Global Clinical Trials Review, H1 2019
GlobalData's clinical trial report, “Colon Cancer Global Clinical Trials Review, H1, 2019" provides an overview of Colon Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Colon Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Cutaneous B-Cell Lymphoma Disease - Global Clinical Trials Review, H1 2019
GlobalData's clinical trial report, “Cutaneous B-Cell Lymphoma Global Clinical Trials Review, H1, 2019" provides an overview of Cutaneous B-Cell Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on Cutaneous B-Cell Lymphoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Cutaneous T-Cell Lymphoma Disease - Global Clinical Trials Review, H1 2019
GlobalData's clinical trial report, “Cutaneous T-Cell Lymphoma Global Clinical Trials Review, H1, 2019" provides an overview of Cutaneous T-Cell Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on Cutaneous T-Cell Lymphoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.